Christoph joined Neuraxpharm in August 2017 from DSM Sinochem Pharmaceuticals, where he had been developing the business-to-business licensing of drug products. He is responsible for the Group’s product portfolio, including both in- and out-licensing activities, as well as for growing Neuraxpharm’s footprint through his International Trade Business team. Christoph has more than 15 years of industry experience, having previously worked in leading business development roles for Heumann Pharma, the German subsidiary of Torrent Pharmaceuticals, and Helm in Hamburg. Originally a scientist with a PhD in Organic Chemistry from the University of Cologne, Christoph has lived in Belgium, Germany and the Netherlands and is now based in Barcelona.